Sansure Biotech (SHSE:688289) ROCE % : 1.89% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Sansure Biotech ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sansure Biotech's annualized ROCE % for the quarter that ended in Sep. 2024 was 1.89%.

Sansure Biotech ROCE % Historical Data

The historical data trend for Sansure Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sansure Biotech ROCE % Chart

Sansure Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

9.42

115.05

46.75

33.05

5.46

Sansure Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															13.17	3.18	5.02	4.10	1.89

Sansure Biotech ROCE % Calculation

Sansure Biotech's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	412.887	/	( ( (9173.762 - 1571.726)	+	(8454.205 - 919.153) )	/ 2 )
	=	412.887	/	( (7602.036	+	7535.052)	/ 2 )
	=	412.887	/	7568.544
	=	5.46 %

Sansure Biotech's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	149.532	/	( ( (8632.08 - 671.039)	+	(8571.194 - 714.28) )	/ 2 )
	=	149.532	/	( ( 7961.041	+	7856.914 )	/ 2 )
	=	149.532	/	7908.9775
	=	1.89 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Sansure Biotech (SHSE:688289) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sansure Biotech ROCE % Related Terms

Thank you for viewing the detailed overview of Sansure Biotech's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sansure Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205

Website

http://www.sansure.com.cn

Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.

Executives

Tan De Yong	Core technical personnel
Wang Hai Xiao	senior management
Jie Ya Ping	Core technical personnel
Zhang Ke Ya	Core technical personnel
Yang Li	Core technical personnel
Liu Rang Jiao	Core technical personnel
Deng Zhong Ping	Senior management, core technical personnel
Zhou Jun	senior management
Zhu Jian	senior management
Wu Kang	Core technical personnel
Xiong Xiao Yan	senior management
Ji Bo Zhi	Core technical personnel
Mou Wei Min	Core technical personnel
Ren Xiao Mei	Core technical personnel
Liu Kai	senior management

Sansure Biotech Headlines

No Headlines